19 completed. 19 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 19 | Completed 19 |
| Phase 3 | 1 | Completed 1 |
Follow Abscess: new trials by email Literature Review of Abscess trials Research Report on Abscess
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) Avacopan, Placebo - Hidradenitis Suppurativa, Acne Inversa | Phase 2 | Completed | Amgen | 435 | 2018-12-21 | 2025-03-17 |
| Systemic and Local Antimicrobials in the Management of Dental Abscess in Children Odontopaste®, Pulpdent, Amoxicillin - Dentoalveolar Abscess | Phase 2 | Completed | University of Malaya | 55 | 2018-09-18 | 2020-05-12 |
| Resolution of Pain and Swelling After the Use of Neem Leaf Extract Compared to Chlorhexidine Gluconate as an Intracanal Irrigant During Pulpectomy Neem leaf extract, Chlorhexidine gluconate - Periapical Abscess | Phase 2 / Phase 3 | Completed | Cairo University | 40 | 2016-12-01 | 2019-07-31 |
| Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections Daptomycin, Brilacidin - Skin Infection, Bacterial Infection | Phase 2 | Completed | Cellceutix Corporation | 215 | 2014-02-01 | 2018-09-26 |
| Laparoscopic Management of Periappendicular Abscess Laparoscopic appendectomy, Conservative management with percutaneous drainage - Appendicitis, Abdominal Abscess | Phase 2 | Completed | Helsinki University Central Hospital | 60 | 2011-01-01 | 2014-09-23 |
| Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox) JNJ-32729463, linezolid, JNJ-32729463 placebo - Complicated Skin and Skin Structure Infections | Phase 2 | Completed | Furiex Pharmaceuticals, Inc | 161 | 2010-06-01 | 2011-12-16 |
| Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa adalimumab, Placebo - Hidradenitis Suppurativa | Phase 2 | Completed | Abbott | 154 | 2009-04-01 | 2011-05-09 |
| Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus Trimethoprim-sulfamethoxazole, Placebo, Clindamycin - Staphylococcal Infection | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 1310 | 2009-04-01 | 2016-03-17 |
| Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage Type of dressing - Iodoform, Type of dressing - Aquacel - Abscess, Cellulitis | Phase 2 | Completed | Valleywise Health | 92 | 2008-03-01 | 2017-10-04 |
| Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections ceftaroline, linezolid, Aztreonam - Bacterial Infection | Phase 2 | Completed | Forest Laboratories | 150 | 2008-02-01 | 2017-03-14 |
| Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections Radezolid, Linezolid - Infectious Skin Diseases, Bacterial Skin Diseases | Phase 2 | Completed | Melinta Therapeutics, Inc. | 150 | 2007-12-01 | 2014-03-27 |
| A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia Imipenem/cilastatin, Doripenem - Pneumonia, Ventilator-Associated, Pneumonia, Bacterial | Phase 2 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 146 | 2007-10-01 | 2019-03-19 |
| A Study for Patients With Complicated Skin and Skin Structure Infections oritavancin - Staphylococcal Skin Infections, Wounds and Injuries | Phase 2 | Completed | Targanta Therapeutics Corporation | 294 | 2007-08-01 | 2008-08-14 |
| Comparison of Suturing and Packing of Drained Abscesses PRIMARY CLOSRE, SECONDARY CLOSURE, SPONTANEOUS HALING - Cutanoeus Abscesses | Phase 2 | Completed | Stony Brook University | 100 | 2007-01-01 | 2012-10-22 |
| Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses Alteplase, saline - Abdominal Abscess, Pelvic Abscess | Phase 2 | Completed | Kaiser Permanente | 20 | 2006-02-01 | 2015-02-26 |
| Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) Telavancin, vancomycin or antistaphylococcal penicillin - Infections, Gram-positive Bacterial | Phase 2 | Completed | Cumberland Pharmaceuticals | 201 | 2004-02-01 | 2019-01-16 |
| Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) Telavancin, Vancomycin or antistaphylococcal penicillin - Infections, Gram-Positive Bacterial, Abscess | Phase 2 | Completed | Cumberland Pharmaceuticals | 169 | 2003-06-01 | 2019-01-16 |
| Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis Sulfadiazine, Clarithromycin, Atovaquone - Toxoplasmosis, Cerebral, HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 100 | 2021-10-28 | |
| Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients Pyrimethamine, Leucovorin calcium - Toxoplasmosis, Cerebral, HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 150 | 2021-11-02 |
Cellulitis (8) · Wound Infection (5) · Bacterial Infections (4) · Abdominal Abscess (3) · Gram-Positive Bacterial Infections (3) · Acquired Immunodeficiency Syndrome (2) · Burns (2) · HIV Infections (2) · Hidradenitis Suppurativa (2) · Periapical Abscess (2) · Skin Diseases (2) · Skin Diseases, Infectious (2) · Staphylococcal Infections (2) · Staphylococcal Skin Infections (2)
Infections (19) · Suppuration (19) · Pathologic Processes (13) · Pathological Conditions, Signs and Symptoms (13) · Inflammation (12) · Bacterial Infections and Mycoses (11) · Skin and Connective Tissue Diseases (11) · Skin Diseases, Infectious (9) · Connective Tissue Diseases (8) · Bacterial Infections (7) · Gram-Positive Bacterial Infections (4) · Skin Diseases (4) · Skin Diseases, Bacterial (4) · Blood-Borne Infections (2)
Linezolid (3) · Leucovorin (2) · Pyrimethamine (2) · Vancomycin (2) · telavancin (2) · Adalimumab (1) · Amoxicillin (1) · Atovaquone (1) · Aztreonam (1) · Ceftaroline (1) · Cilastatin, Imipenem Drug Combination (1) · Clarithromycin (1) · Clindamycin (1) · Conservative Treatment (1) · Daptomycin (1)
National Institute of Allergy and Infectious Diseases (NIAID) (3) · Cumberland Pharmaceuticals (2) · Abbott (1) · Amgen (1) · Cairo University (1) · Cellceutix Corporation (1) · Forest Laboratories (1) · Furiex Pharmaceuticals, Inc (1) · Helsinki University Central Hospital (1) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1) · Kaiser Permanente (1) · Melinta Therapeutics, Inc. (1) · Stony Brook University (1) · Targanta Therapeutics Corporation (1) · University of Malaya (1)
United States (15) · Australia (1) · Denmark (1) · Egypt (1) · Finland (1) · Germany (1) · India (1) · Italy (1) · Malaysia (1) · Netherlands (1) · Romania (1) · Ukraine (1)
G. Ralph Corey, MD (2) · Adam J Singer, MD (1) · BJ Luft (1) · Chirgwin K (1) · Dalia M Moheb, Assoc Prof (1) · Hyo-Chun Yoon, MD, PhD (1) · JL Vilde (1) · Lily Azura Shoaib Dr (1) · Luft B (1) · Madhumita Sinha, MD (1) · Martin Okun, MD, PhD (1) · Norhan A El Dokky, Assoc Prof (1)
PMID 21537018, PMID 23247938, PMID 23570475, PMID 25785967, PMID 27136622, PMID 28657870, PMID 29380251
2008 (1)